This inventor holds 1 USPTO granted patent. Top assignee: University of Delaware. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Amanda M Tallon: Innovator in Bioorthogonal Chemistry
Introduction: Amanda M Tallon is a prominent inventor based in Claymont, Delaware. She has made significant contributions to the field of bioorthogonal chemistry, which is crucial for advancements in biochemistry and molecular biology. Her innovative work has led to the development of methods that enhance chemical reactions in biological systems.
Latest Patents: Amanda holds a patent titled "Methods for inducing bioorthogonal reactivity." This patent describes a method for catalytically converting a dihydrotetrazine into a tetrazine. The process involves providing the dihydrotetrazine in a reaction medium and adding an enzyme as a catalyst along with an oxidant. This innovative method allows for the conversion of dihydrotetrazine into tetrazine, which has important applications in various scientific fields. She has 1 patent to her name.
Career Highlights: Amanda is affiliated with the University of Delaware, where she conducts her research and contributes to the academic community. Her work is recognized for its potential impact on the development of new chemical processes that can be applied in medical and scientific research.
Collaborations: Amanda has collaborated with notable colleagues such as Joseph M Fox and Colin Thorpe. These partnerships have further enriched her research and expanded the scope of her innovative work.
Conclusion: Amanda M Tallon is a remarkable inventor whose contributions to bioorthogonal chemistry are paving the way for new advancements in the field. Her dedication to research and innovation continues to inspire future developments in science.